Submitted by Anonymous (not verified) on 23 October 2023 - 12:16
Human medicines European public assessment report (EPAR): Neulasta, pegfilgrastim, Neutropenia;Cancer, Date of authorisation: 22/08/2002, Revision: 39, Status: Authorised
Source: